{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:32:36Z","timestamp":1793385156966,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014535","name":"Center for Individualized Medicine, Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015138","name":"J Willard and Alice S Marriott Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015138","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122257","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:28:47Z","timestamp":1783924127000},"page":"122257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pooled analysis assessing the efficacy and safety of amphetamine derivative adjunctive therapy for bipolar depression"],"prefix":"10.1016","volume":"414","author":[{"given":"Mark A.","family":"Frye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Sanchez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina N.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa K.","family":"Pazdernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo B.","family":"Cuellar-Barboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Veldic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Ozerdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Biernacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122257_bb0005","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/biom16020324","article-title":"Glutamate metabotropic receptors-linked postsynaptic density proteins: an emergent hub for antipsychotics\u2019 regulation of synaptic plasticity and metaplasticity","volume":"16","author":"Barone","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.jad.2026.122257_bb0015","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1073\/pnas.1220552110","article-title":"Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate","volume":"110","author":"Buchmayer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jad.2026.122257_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007813.pub3","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults","author":"Castells","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2026.122257_bb0025","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jad.2026.122257_bb0030","article-title":"Differentiation and comorbidity of bipolar disorder and attention deficit and hyperactivity disorder in children, adolescents, and adults: a clinical and nosological perspective","volume":"13","author":"Comparelli","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122257_bb0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S2215-0366(25)00248-2","article-title":"Psychotic symptoms during pharmacological treatment of ADHD: clinical considerations and research needs","volume":"13","author":"Cortese","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2006.07.035","article-title":"Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain","volume":"52","author":"Easton","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2026.122257_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.122257_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2215-0366(25)00062-8","article-title":"Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"12","author":"Farhat","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaac.2025.09.012","article-title":"Individual participant data meta-analysis: moderators of response to stimulants for preschool attention-deficit\/hyperactivity disorder","volume":"65","author":"Farhat","year":"2026","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0065","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","article-title":"A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression","volume":"164","author":"Frye","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0070","first-page":"74","article-title":"P110. Addressing efficacy and safety of mixed amphetamine salt as an adjunctive therapy for bipolar depression","volume":"51","author":"Frye","year":"2026","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122257_bb0075","article-title":"Racial differences in pathways to care preceding first episode mania or psychosis: a historical cohort prodromal study","volume":"14","author":"Gardea-Resendez","year":"2023","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122257_bb0080","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4088\/JCP.13r08560","article-title":"Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials","volume":"74","author":"Goss","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/0033-2909.117.1.167","article-title":"Meta-analysis of screening and diagnostic tests","volume":"117","author":"Hasselblad","year":"1995","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2026.122257_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pharmthera.2014.03.005","article-title":"Preclinical pharmacology of amphetamine: implications for the treatment of neuropsychiatric disorders","volume":"143","author":"Hutson","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2026.122257_bb0095","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/15563650.2015.1027903","article-title":"Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers","volume":"53","author":"Kaland","year":"2015","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.jad.2026.122257_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2910","article-title":"Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine\u2014a literature review","volume":"39","author":"K\u00e4mmerer","year":"2024","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jad.2026.122257_bb0105","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","article-title":"Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine","volume":"68","author":"Kuczenski","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jad.2026.122257_bb0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awaf335","article-title":"Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation","volume":"149","author":"Leong","year":"2026","journal-title":"Brain"},{"key":"10.1016\/j.jad.2026.122257_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120393","article-title":"Global, regional and national burden of bipolar disorder: an analysis of trends from 1990 to 2021","volume":"393","author":"Liu","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/138161210790361416","article-title":"Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex","volume":"16","author":"L\u00f3pez-Gil","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jad.2026.122257_bb0130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jnc.13582","article-title":"Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies","volume":"137","author":"\u0141ukasiewicz","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jad.2026.122257_bb0135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41380-021-01294-9","article-title":"Sex differences in methylphenidate-induced dopamine increases in ventral striatum","volume":"27","author":"Manza","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2510642122","article-title":"Spontaneous glutamate release activates mGluR signaling to drive rapid antidepressant responses","volume":"122","author":"McCarthy","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jad.2026.122257_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/YIC.0000000000000051","article-title":"Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial","volume":"30","author":"McElroy","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122257_bb0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/JCP.0000000000000723","article-title":"The efficacy of psychostimulants in major depressive episodes: a systematic review and meta-analysis","volume":"37","author":"McIntyre","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122257_bb0155","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.122257_bb0160","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamapsychiatry.2023.0131","article-title":"Association between the fronto-limbic network and cognitive and emotional functioning in individuals with bipolar disorder: a systematic review and meta-analysis","volume":"80","author":"Mesbah","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2026.122257_bb0165","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0165-0327(14)70003-5","article-title":"The prevalence and burden of bipolar depression","volume":"169","author":"Miller","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bdi.12534","article-title":"Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force","volume":"19","author":"Miskowiak","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0175","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bdi.13414","article-title":"Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force","volume":"26","author":"Miskowiak","year":"2024","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.120","article-title":"The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression","volume":"7","author":"Morais","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0185","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa1813751","article-title":"Psychosis with methylphenidate or amphetamine in patients with ADHD","volume":"380","author":"Moran","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.122257_bb0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10802-021-00870-5","article-title":"Methylphenidate improves autonomic functioning among youth with attention-deficit\/hyperactivity disorder","volume":"50","author":"Morris","year":"2022","journal-title":"Res. Child. Adolesc. Psychopathol."},{"key":"10.1016\/j.jad.2026.122257_bb0195","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.biopsych.2005.01.036","article-title":"Clinical and diagnostic implications of lifetime attention-deficit\/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants","volume":"57","author":"Nierenberg","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/syn.10189","article-title":"Differential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex","volume":"48","author":"Ninan","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2026.122257_bb0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bdi.12859","article-title":"Efficacy and tolerability of adjunctive modafinil\/armodafinil in bipolar depression: a meta-analysis of randomized controlled trials","volume":"22","author":"Nunez","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0210","article-title":"Clinical and genetic correlates of bipolar disorder with childhood-onset attention deficit disorder","volume":"13","author":"Nunez","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122257_bb0215","doi-asserted-by":"crossref","first-page":"e259492","DOI":"10.1001\/jamanetworkopen.2025.9492","article-title":"Safety of stimulants across patient populations: a meta-analysis","volume":"8","author":"Oliva","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2026.122257_bb0220","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jamapsychiatry.2019.0801","article-title":"Assessment of striatal dopamine transporter binding in individuals with major depressive disorder: in vivo positron emission tomography and postmortem evidence","volume":"76","author":"Pizzagalli","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18084368","article-title":"The management of psychomotor agitation associated with schizophrenia or bipolar disorder: a brief review","volume":"18","author":"Pompili","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2026.122257_bb0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopsych.2025.02.903","article-title":"Current evidence for the role of rapid-acting antidepressants in bipolar depression: a perspective and plan for action","volume":"98","author":"Repple","year":"2025","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2026.122257_bb0235","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1176\/appi.ajp.2020.19091000","article-title":"20-Year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings","volume":"177","author":"Rhee","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0240","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2026.122257_bb0245","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0250","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.70074","article-title":"Mapping the global burden and inequalities of bipolar disorder, 1990\u20132021, with projections to 2050: a systematic analysis","volume":"28","author":"Saeed","year":"2026","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0255","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamapsychiatry.2025.2311","article-title":"Occurrence of psychosis and bipolar disorder in individuals with attention-deficit\/hyperactivity disorder treated with stimulants: a systematic review and meta-analysis","volume":"82","author":"Salazar de Pablo","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0260","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(25)01140-7","article-title":"Bipolar disorder","volume":"406","author":"Singh","year":"2025","journal-title":"The Lancet."},{"key":"10.1016\/j.jad.2026.122257_bb0265","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mayocp.2025.12.005","article-title":"Acute cardiovascular responses to amphetamine\/dextroamphetamine salts (adderall) in adderall-Na&#xef;ve young adults: a randomized clinical trial","volume":"101","author":"Somers","year":"2026","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jad.2026.122257_bb0270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/acps.12712","article-title":"Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"135","author":"Szmulewicz","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122257_bb0275","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1124\/jpet.103.052597","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment","volume":"306","author":"Tarazi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2026.122257_bb0280","article-title":"Health disparities in the treatment of bipolar disorder","volume":"37-38","author":"Tchikrizov","year":"2023","journal-title":"Personal. Med. Psychiatry"},{"key":"10.1016\/j.jad.2026.122257_bb0285","first-page":"1","article-title":"Adjunctive treatment with psychostimulants and stimulant-like drugs for resistant bipolar depression: a systematic review and meta-analysis","author":"Tsapakis","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2026.122257_bb0290","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuron.2014.05.043","article-title":"Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons","volume":"83","author":"Underhill","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2026.122257_bb0295","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/JCP.0000000000001407","article-title":"Pramipexole to improve cognition in bipolar disorder: a randomized controlled trial","volume":"41","author":"Van Meter","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jad.2026.122257_bb5005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bdi.70048","article-title":"Defining Treatment-Resistant Bipolar Depression: Recommendations From the ISBD Task Force","author":"Vieta","year":"2025","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122257_bb0300","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41386-018-0027-7","article-title":"Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans","volume":"43","author":"White","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122257_bb0305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamapsychiatry.2023.4294","article-title":"Attention-deficit\/hyperactivity disorder medications and long-term risk of cardiovascular diseases","volume":"81","author":"Zhang","year":"2024","journal-title":"JAMA Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:58:58Z","timestamp":1793383138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726011109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":62,"alternative-id":["S0165032726011109"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122257","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pooled analysis assessing the efficacy and safety of amphetamine derivative adjunctive therapy for bipolar depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122257"}}